Gastroparese-Markt – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPRE00008992
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 155
Buy Now

[Forschungsbericht]Der Gastroparese-Markt wurde 2019 auf 4.338,61 Millionen US-Dollar geschätzt und soll bis 2027 6.025,11 Millionen US-Dollar erreichen; Es wird erwartet, dass sie von 2020 bis 2027 mit einer durchschnittlichen jährlichen Wachstumsrate von 4,3 % wächst. Gastroparese ist eine Erkrankung, die durch die Unfähigkeit des Magens gekennzeichnet ist, sich auf die übliche Weise von der Nahrung zu entleeren. Geschädigte Nerven wie Vagusnerven und Muskeln, die mit der Magenmotilität verbunden sind, können ebenfalls zu einer Gastroparese führen. Die Erkrankung wird häufig bei Diabetikern beobachtet. Gastroparese kann je nach Ursache in diabetische, idiopathische und postoperative Erkrankungen eingeteilt werden. Abgesehen davon können auch Virusinfektionen, Nervenerkrankungen, übermäßiger Konsum von Betäubungsmitteln und verschiedenen Antidepressiva sowie Amyloidose zum Ausbruch einer Gastroparese führen.



Die COVID-19-Pandemie hat die Lieferkette von Over-the-Arzneimitteln unterbrochen Dies dürfte das Marktwachstum in den nächsten Quartalen begrenzen. Darüber hinaus hat die Konzentration von Gesundheitsdienstleistern und Medizinindustrie auf COVID-19 dazu geführt, dass der Schwerpunkt weniger auf der Diagnose und Behandlung von Gastroparese liegt, was das Marktwachstum in gewissem Maße einschränkt.



Lukrative Regionen für Gastroparese-Markt



Markteinblicke



Steigende geriatrische Bevölkerung beschleunigt die Nachfrage nach Gastroparese-Behandlungsmodalitäten



Die Magenentleerung ist mit der Koordination zwischen der motorischen Aktivität des proximalen Magens und des distalen Magens verbunden Magen und Zwölffingerdarm. Diese inneren Organe werden durch den Rückkopplungsmechanismus neuronaler Signale gesteuert, die durch die Interaktion zwischen Nährstoffen und dem Dünndarm erzeugt werden. Alterung führt zu einer verminderten homöostatischen Regulierung physiologischer Funktionen und zu einer Verlangsamung der Magenentleerung. Darüber hinaus beeinflusst es motorische und sensorische Funktionen. Darüber hinaus ist die geriatrische Bevölkerung aufgrund von Faktoren wie schlechter oraler Medikamentenaufnahme, unzureichender Appetitregulierung und postprandialer Glykämie sehr anfällig für Gastroparese. Laut der Überarbeitung der World Population Prospects aus dem Jahr 2019 würde im Jahr 2050 jeder sechste Mensch älter als 65 Jahre sein, was einem Anstieg gegenüber 1 von 11 im Jahr 2019 entspricht. Darüber hinaus ist laut derselben Studie jeder vierte Mensch in Europa und Nordamerika betroffen Schätzungen zufolge wird die Zahl der über 65-Jährigen im Jahr 2050 über 65 Jahre alt sein. Außerdem würde die Zahl der über 80-Jährigen im Jahr 2050 von 143 Millionen im Jahr 2019 auf 426 Millionen ansteigen Magenentleerung bei diesen Bevölkerungsgruppen treibt das Wachstum des Gastroparese-Marktes voran.



Typbasierte Erkenntnisse



Auf der Grundlage des Typs wird der Gastroparese-Markt in idiopathische, diabetische, postoperative und und andere. Das idiopathische Segment hielt 2019 den größten Marktanteil, während das Diabetikersegment im Prognosezeitraum voraussichtlich die höchste CAGR verzeichnen wird.



Gastroparese-Markt, nach Typ – 2019 und 2027



< h3>Einblicke in die Art der Medikamentenklasse

Der Gastroparese-Markt ist je nach Medikamentenklasse in Prokinetika, Antiemetika und Botulinumtoxin-Injektionen unterteilt. Das Segment der prokinetischen Wirkstoffe hielt 2019 den größten Marktanteil und wird voraussichtlich im Zeitraum 2020–2027 die höchste CAGR verzeichnen.



Vertriebskanalbasierte Einblicke



Auf der Grundlage des Vertriebskanals Der Gastroparese-Markt ist in Krankenhausapotheken, Einzelhandelsapotheken und andere unterteilt. Das Segment der Krankenhausapotheken hielt 2019 den größten Marktanteil, und es wird geschätzt, dass der Markt dafür von 2020 bis 2027 mit der höchsten CAGR wachsen wird.



Strategische Einblicke



The Die Marktteilnehmer für Gastroparese haben die Strategie der Produktinnovationen übernommen, um den dynamischen Kundenanforderungen gerecht zu werden, wodurch sie auch ihren Markennamen auf dem Weltmarkt behaupten können.



Markt für Gastroparese – nach Typ



  • Idiopathisch

  • Diabetisch

  • Postoperativ

  • Andere

Gastroparese-Markt – nach Arzneimittelklassentyp< /h3>

  • Prokinetische Wirkstoffe

  • Botulinumtoxin-Injektionen

  • Antiemetische Wirkstoffe

Gastroparese-Markt – nach Vertriebskanal


  • Krankenhausapotheken

  • Einzelhandelsapotheken

  • Andere

GastropareseMarkt – nach Geografie



  • Nordamerika

    • USA

    • Kanada

    • Mexiko



  • Europa

    • Frankreich< /li>
    • Deutschland

    • Italien

    • Großbritannien

    • Spanien

    • Restliches Europa

    < /li>
  • Asien-Pazifik (APAC)

    • China

    • Indien

    • Südkorea

    • Japan

    • Australien

    • Rest von APAC



  • Naher Osten und Afrika (MEA)

    • Südafrika

    • Saudi-Arabien

    • VAE

    • Rest von MEA



  • Südamerika und Mittelamerika (SCAM)

    • Brasilien
    • Argentinien

    • Rest von SCAM



Unternehmensprofile




  • EVOKE PHARMA
  • Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)

  • Johnson and Johnson Services, Inc.

  • Allergan Plc

  • NEUROGASTRX, INC .

  • TEVA PHARMACEUTICAL INDUSTRIES LTD

  • Pfizer Inc.

  • ANI Pharmaceuticals, Inc.

  • Ipca Laboratories Ltd.
  • < li>Cinrx Pharma, LLC (Cindome Pharma)
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is gastroparesis?

Gastroparesis is a condition where the stomach cannot empty itself of food in the usual way. Moreover, the damaged nerves such as vagus nerves and muscles associated with gastric motility may also lead to gastroparesis. The condition is substantially observed in the diabetic population. Gastroparesis can be classified as diabetic, idiopathic, and post-surgical on the basis of causes. Apart from these viral infections, nerve-related diseases, excessive consumption of narcotics and some antidepressants, and amyloidosis may also lead to the occurrence of gastroparesis.

What are the driving factors for the gastroparesis market across the globe?

The growth of the market is attributed to some key driving factors such as increasing prevalence of diabetes and growing geriatric population.

Who are the major players in the gastroparesis market?

The gastroparesis market majorly consists of the players such as EVOKE PHARMA, Bausch Health Companies Inc.(Salix Pharmaceuticals, Ltd.), Johnson And Johnson Services, Inc., Allergan Plc, NEUROGASTRX, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD, Pfizer Inc., ANI Pharmaceuticals, Inc., Ipca Laboratories Ltd., And Cinrx Pharma, LLC (Cindome Pharma) amongst others.

The List of Companies - Gastroparesis Market

  1. EVOKE PHARMA
  2. Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  3. Johnson and Johnson Services, Inc.
  4. Allergan Plc
  5. NEUROGASTRX, INC.
  6. TEVA PHARMACEUTICAL INDUSTRIES LTD
  7. Pfizer Inc.
  8. ANI Pharmaceuticals, Inc.
  9. Ipca Laboratories Ltd.
  10. Cinrx Pharma, LLC (Cindome Pharma)  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports